Literature DB >> 27664094

MicroRNA-463-3p/ABCG4: A new axis in glucose-stimulated insulin secretion.

Xuwei Hou1, Wei Wu2, Bo Yin3, Xuefeng Liu1, Fu Ren4.   

Abstract

OBJECTIVE: Glucose-stimulated insulin secretion (GSIS) is known to be essential in the control of metabolic fuel homeostasis, though the molecular mechanisms involved remain unclear.
METHODS: MicroRNA (miRNA)-463-3p and ATP-binding cassette A4 (ABCG4) expression was analyzed by real-time PCR, and the potential role of miRNA-463-3p or ABCG4 was evaluated by overexpressing or silencing such miRNA or genes.
RESULTS: The miRNA-463-3p inhibited GSIS without affecting cell viability. Further, mechanistic studies demonstrated that ABCG4 was a direct target of microRNA-463-3p and, to this effect, that ABCG4 played an important role in GSIS. The targeting was relevant in pancreatic islet β-cells, where GSIS through the miRNA-463-3p/ABCG4 axis was observed. Interestingly, in type 2 diabetes human pancreatic islets, expression of miRNA-463-3p and insulin was upregulated and ABCG4 downregulated compared with nondiabetic controls, and their expression levels were closely correlated.
CONCLUSIONS: The findings collectively establish a link between GSIS and the miRNA-463-3p/ABCG4 axis and represent a promising target for future diabetes mellitus treatments.
© 2016 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27664094     DOI: 10.1002/oby.21655

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

1.  The miR-9b microRNA mediates dimorphism and development of wing in aphids.

Authors:  Feng Shang; Jinzhi Niu; Bi-Yue Ding; Wei Zhang; Dan-Dan Wei; Dong Wei; Hong-Bo Jiang; Jin-Jun Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-26       Impact factor: 11.205

Review 2.  Micromanaging Glucose Tolerance and Diabetes.

Authors:  Negar Saliani; Soheila Montazersaheb; Shideh Montasser Kouhsari
Journal:  Adv Pharm Bull       Date:  2017-12-31

3.  A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.

Authors:  Yuqing He; Yuanlin Ding; Biyu Liang; Juanjuan Lin; Taek-Kyun Kim; Haibing Yu; Hanwei Hang; Kai Wang
Journal:  Int J Mol Sci       Date:  2017-02-28       Impact factor: 5.923

Review 4.  Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Soheil Madadi; Heidi Schwarzenbach; Massoud Saidijam; Reza Mahjub; Meysam Soleimani
Journal:  Cell Biosci       Date:  2019-11-12       Impact factor: 7.133

5.  miR-1185-1 and miR-548q Are Biomarkers of Response to Weight Loss and Regulate the Expression of GSK3B.

Authors:  Marcos Garcia-Lacarte; Maria L Mansego; M Angeles Zulet; J Alfredo Martinez; Fermin I Milagro
Journal:  Cells       Date:  2019-11-30       Impact factor: 6.600

6.  T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.

Authors:  Jyoti Rani; Inna Mittal; Atreyi Pramanik; Namita Singh; Namita Dube; Smriti Sharma; Bhanwar Lal Puniya; Muthukurussi Varieth Raghunandanan; Ahmed Mobeen; Srinivasan Ramachandran
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 7.  Crosstalk Between the Unfolded Protein Response, MicroRNAs, and Insulin Signaling Pathways: In Search of Biomarkers for the Diagnosis and Treatment of Type 2 Diabetes.

Authors:  Chinar Berry; Megha Lal; B K Binukumar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-02       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.